Global Small interfering RNA (siRNA) Therapeutics Market : Industry Analysis and Forecast (2020-2026) By Type, Applications and Region

Global Small interfering RNA (siRNA) Therapeutics Market was valued $XX Mn in 2019 and is expected to reach $XX Mn by 2026, at a CAGR of XX% during a forecast period.

Global Small interfering RNA (siRNA) Therapeutics Market Overview:

Small Interfering RNAs, also called as silencing RNA, is a class of double stranded non-coding RNA molecules. These are the most widely used nucleic acid based sequence for interfering expression of specific genes. The siRNAs help to recognize unique pathways and to validate targets for various life threatening diseases such as cancer, AIDS etc.

Global Small interfering RNA (siRNA) Therapeutics Market Dynamics:

Higher efficiency of the siRNA compared to earlier reverse genetic technologies is considered to be the prime factor driving the market growth. siRNA has a widespread applicationas it is used to assess cellular phenotypes including cytokinesis, apoptosis, insulin signalling and cell differentiation.High potential of gene silencing of siRNA has resulted in many target specific therapeutic applications for validating targets in cancer, HIV infection, hepatitis etc. Rising number of clinical trials, short duration of pre-clinical development, rising government funding for research and developmental activities, well-established healthcare infrastructure are key drivers which augment the market growth. Moreover, rising prevalence of cancer and it is the leading cause of deathworldwide, small interfering RNAs (siRNAs) have been considered one of the most noteworthy developments which are able to regulate gene expression following a process known as RNA interference (RNAi). These factors positively impact on the market growth. The report has profiled fifteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed.

Global Small interfering RNA (siRNA) Therapeutics Market Segment Analysis:

The global Small Interfering RNA (siRNA) therapeutics market is segmented on the basis of Type and Application. Based on Type, the liposome based systemic therapy segment is expected to hold a dominant market share, as it proves to be the promising drug delivery system in for in vivo siRNA delivery. Liposomes are the first nano drug delivery systems that have been successfully translated into real-time clinical applications. The second and third generation of liposomes have the ability to recognize specific receptors or enhance the liposome stabitlities, which increase the use of liposome based delivery systems most used in clinical applications. All these factors help in bolstering the segment growth. Global Small interfering RNA (siRNA) Therapeutics Market1 To Know About The Research Methodology :- Request Free Sample Report

Global Small interfering RNA (siRNA) Therapeutics Market Regional Insights:

Regional Insights North America is expected to dominate the global market during the forecast period. Rising number of clinical trials and new product launches in the region contribute to the market growth. In addition to this, increase in healthcare expenditure, government funding for research & development activities, well established healthcare infrastructure create the potential opportunities for the market growth in the region. APAC is expected to witness a lucrative growth during the forecast period. Rising awareness about the availability of various therapies available to treat chronic diseases like cancer, cardiovascular diseases and others, increasing healthcare expenditure and presence of favourable reimbursement policies by government drives the market growth in the region. The report also helps in understanding the Global Small interfering RNA (siRNA) Therapeutics Market dynamics, structure by analyzing the market segments and project the Global Small interfering RNA (siRNA) Therapeutics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Small interfering RNA (siRNA) Therapeutics Market make the report investor’s guide.

Scope of the Global Small interfering RNA (siRNA) Therapeutics Market Report: Inquire before buying

Global Small interfering RNA (siRNA) Therapeutics Market2

Global Small interfering RNA (siRNA) Therapeutics Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Small interfering RNA (siRNA) Therapeutics Market Key Players

• GE Dharmacon • OPKO Health, Inc. • Alnylam Pharmaceuticals • Arrowhead Research Corp • Sanofi Genzyme • Genecon Biotechnologies Co., Ltd. • Arbutus Biopharma Corp • Silence Therapeutics AG • Sylentis S.A. • Olix Pharmaceuticals • GlaxoSmithKline • Isis Pharmaceuticals/ Ionis Pharmaceuticals • BenitecBiopharma Ltd. • Bio-Path Holdings Inc. • Calando Pharmaceuticals

Global Small interfering RNA (siRNA) Therapeutics Market

1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Small interfering RNA (siRNA) Therapeutics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Small interfering RNA (siRNA) Therapeutics Market 3.4. Geographical Snapshot of the Small interfering RNA (siRNA) Therapeutics Market, By Manufacturer share 4. Global Small interfering RNA (siRNA) Therapeutics Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Small interfering RNA (siRNA) Therapeutics Market 5. Supply Side and Demand Side Indicators 6. Global Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecast, 2019-2026 6.1. Global Small interfering RNA (siRNA) Therapeutics Market Size & Y-o-Y Growth Analysis. 7. Global Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 7.1.1. Liposome Based Systemic Therapy 7.1.2. Nanoparticle Based Systemic Therapy 7.1.3. Other 7.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 7.2.1. Hospital, Research Institutions 7.2.2. Pharmaceutical and Biotechnology Companies 7.2.3. Academic Institutions 7.2.4. Other 8. Global Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 9.1.1. Liposome Based Systemic Therapy 9.1.2. Nanoparticle Based Systemic Therapy 9.1.3. Other 9.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 9.2.1. Hospital, Research Institutions 9.2.2. Pharmaceutical and Biotechnology Companies 9.2.3. Academic Institutions 9.2.4. Other 10. North America Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 12. Canada Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 13. Mexico Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 14. Europe Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 15. Europe Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 17. France Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 18. Germany Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 19. Italy Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 20. Spain Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 21. Sweden Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 22. CIS Countries Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 23. Rest of Europe Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 24. Asia Pacific Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 25. Asia Pacific Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 27. India Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 28. Japan Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 29. South Korea Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 30. Australia Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 31. ASEAN Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 32. Rest of Asia Pacific Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 33. Middle East Africa Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 34. Middle East Africa Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 36. GCC Countries Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 37. Egypt Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 38. Nigeria Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 39. Rest of ME&A Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 40. South America Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 41. South America Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 43. Argentina Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 44. Rest of South America Small interfering RNA (siRNA) Therapeutics Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Applications, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Small interfering RNA (siRNA) Therapeutics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. GE Dharmacon 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. OPKO Health, Inc. 45.3.3. Alnylam Pharmaceuticals 45.3.4. Arrowhead Research Corp 45.3.5. Sanofi Genzyme 45.3.6. Genecon Biotechnologies Co., Ltd. 45.3.7. Arbutus Biopharma Corp 45.3.8. Silence Therapeutics AG 45.3.9. Sylentis S.A. 45.3.10. Olix Pharmaceuticals 45.3.11. GlaxoSmithKline 45.3.12. Isis Pharmaceuticals/ Ionis Pharmaceuticals 45.3.13. BenitecBiopharma Ltd. 45.3.14. Bio-Path Holdings Inc. 45.3.15. Calando Pharmaceuticals 46. Primary Key Insights

About This Report

Report ID 91788
Category Healthcare
Published Date April 2021
Updated Date
Contact Us